Abstract
Diabetic retinopathy (DR) is a devastating complication of diabetes with a prevalence rate of 35%, and no effective treatment options. Since the most visible clinical features of DR are microvascular irregularities, therapeutic interventions often attempt to reduce microvascular injury, but only after permanent retinal damage has ensued. However, recent data suggests that diabetes initially affects retinal neurons, leading to neurodegeneration as an early occurrence in DR, before onset of the more noticeable vascular abnormalities. In this review, we delineate the sequence of initiating events leading to retinal degeneration in DR, considering neuronal dysfunction as a primary event. Key molecular mechanisms and potential biomarkers associated with retinal neuronal degeneration in diabetes are discussed. In addition to glial reactivity and inflammation in the diabetic retina, the contribution of neurotrophic factors, cell adhesion molecules, apoptosis markers, and G protein signaling to neurodegenerative pathways warrants further investigation. These studies could complement recent developments in innovative treatment strategies for diabetic retinopathy, such as targeting retinal neuroprotection, promoting neuronal regeneration, and attempts to re-program other retinal cell types into functional neurons. Indeed, several ongoing clinical trials are currently attempting treatment of retinal neurodegeneration by means of such novel therapeutic avenues. The aim of this article is to highlight the crucial role of neurodegeneration in early retinopathy progression, and to review the molecular basis of neuronal dysfunction as a first step toward developing early therapeutic interventions that can prevent permanent retinal damage in diabetes. ClinicalTrials.gov: NCT02471651, NCT01492400
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abcouwer SF (2013) Angiogenic factors and cytokines in diabetic retinopathy. J Clin Cell Immunol Suppl 1. https://doi.org/10.4172/2155-9899
Abcouwer SF, Gardner TW (2014) Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci 1311:174–190. https://doi.org/10.1111/nyas.12412
Abu El-Asrar AM, Dralands L, Missotten L, Geboes K (2007) Expression of antiapoptotic and proapoptotic molecules in diabetic retinas. Eye 21:238–245. https://doi.org/10.1038/sj.eye.6702225
Abu-El-Asrar AM, Dralands L, Missotten L et al (2004) Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 45:2760–2766. https://doi.org/10.1167/iovs.03-1392
ACCORD Study Group, ACCORD Eye Study Group, Chew EY et al (2010) Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 363:233–244. https://doi.org/10.1056/NEJMoa1001288
Agardh CD, Agardh E, Zhang H, Ostenson CG (1997) Altered endothelial/pericyte ratio in Goto-Kakizaki rat retina. J Diabetes Complicat 11:158–162
Ahrén B (2009) Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 8:369–385. https://doi.org/10.1038/nrd2782
Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487. https://doi.org/10.1056/NEJM199412013312203
Aiello LP, Gardner TW, King GL et al (1998) Diabetic retinopathy. Diabetes Care 21:143–156
Aizu Y, Katayama H, Takahama S et al (2003) Topical instillation of ciliary neurotrophic factor inhibits retinal degeneration in streptozotocin-induced diabetic rats. Neuroreport 14:2067–2071. https://doi.org/10.1097/01.wnr.0000097044.56589.78
Antonetti DA, Barber AJ, Bronson SK et al (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55:2401–2411. https://doi.org/10.2337/db05-1635
Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227–1239. https://doi.org/10.1056/NEJMra1005073
Arevalo JF, Maia M, Flynn HW et al (2008) Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 92:213–216. https://doi.org/10.1136/bjo.2007.127142
Asher RA, Morgenstern DA, Moon LD, Fawcett JW (2001) Chondroitin sulphate proteoglycans: inhibitory components of the glial scar. Prog Brain Res 132:611–619. https://doi.org/10.1016/S0079-6123(01)32106-4
Augustin AJ, Kuppermann BD, Lanzetta P et al (2015) Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. BMC Ophthalmol 15:150. https://doi.org/10.1186/s12886-015-0148-2
Augustin HG, Koh GY, Thurston G, Alitalo K (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-tie system. Nat Rev Mol Cell Biol 10:165–177. https://doi.org/10.1038/nrm2639
Bai F, Peng H, Etlinger JD, Zeman RJ (2010) Partial functional recovery after complete spinal cord transection by combined chondroitinase and clenbuterol treatment. Pflugers Arch 460:657–666. https://doi.org/10.1007/s00424-010-0852-y
Ban CR, Twigg SM (2008) Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag 4:575–596
Barber AC, Hippert C, Duran Y et al (2013) Repair of the degenerate retina by photoreceptor transplantation. Proc Natl Acad Sci U S A 110:354–359. https://doi.org/10.1073/pnas.1212677110
Barber AJ, Antonetti DA, Kern TS et al (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210–2218. https://doi.org/10.1167/iovs.04-1340
Barber AJ, Lieth E, Khin SA et al (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783–791. https://doi.org/10.1172/JCI2425
Barnea-Cramer AO, Wang W, Lu S-J et al (2016) Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice. Sci Rep 6:29784. https://doi.org/10.1038/srep29784
Barnstable CJ, Tombran-Tink J (2004) Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. Prog Retin Eye Res 23:561–577. https://doi.org/10.1016/j.preteyeres.2004.05.002
Barouch FC, Miyamoto K, Allport JR et al (2000) Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 41:1153–1158
Barros CS, Franco SJ, Müller U (2011) Extracellular matrix: functions in the nervous system. Cold Spring Harb Perspect Biol 3:a005108. https://doi.org/10.1101/cshperspect.a005108
Berezin V (ed) (2010) Structure and function of the neural cell adhesion molecule NCAM. Springer New York, New York, NY
Blinder KJ, Dugel PU, Chen S et al (2017) Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO study report 1). Clin Ophthalmol Auckl NZ 11:393–401. https://doi.org/10.2147/OPTH.S128509
Bloodworth JM (1962) Diabetic retinopathy. Diabetes 11:1–22
Bode C, Wolfrum U (2003) Caspase-3 inhibitor reduces apototic photoreceptor cell death during inherited retinal degeneration in tubby mice. Mol Vis 9:144–150
Boyer DS, Yoon YH, Belfort R et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121:1904–1914. https://doi.org/10.1016/j.ophtha.2014.04.024
Bresnick GH (1986) Diabetic retinopathy viewed as a neurosensory disorder. Arch Ophthalmol Chic Ill 1960 104:989–990
Bressler SB, Qin H, Beck RW et al (2012) Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Arch Ophthalmol Chic Ill 1960 130:1153–1161. https://doi.org/10.1001/archophthalmol.2012.1107
Brown DM, Nguyen QD, Marcus DM et al (2013) Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 120:2013–2022. https://doi.org/10.1016/j.ophtha.2013.02.034
Brown SP, He S, Masland RH (2000) Receptive field microstructure and dendritic geometry of retinal ganglion cells. Neuron 27:371–383
Bui BV, Loeliger M, Thomas M et al (2009) Investigating structural and biochemical correlates of ganglion cell dysfunction in streptozotocin-induced diabetic rats. Exp Eye Res 88:1076–1083. https://doi.org/10.1016/j.exer.2009.01.009
Busik JV, Mohr S, Grant MB (2008) Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 57:1952–1965. https://doi.org/10.2337/db07-1520
Busskamp V, Duebel J, Balya D et al (2010) Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science 329:413–417. https://doi.org/10.1126/science.1190897
Campochiaro PA, Khanani A, Singer M et al (2016) Enhanced benefit in diabetic macular edema from AKB-9778 Tie2 activation combined with vascular endothelial growth factor suppression. Ophthalmology 123:1722–1730. https://doi.org/10.1016/j.ophtha.2016.04.025
Cen L-P, Liang J-J, Chen J-H et al (2017) AAV-mediated transfer of RhoA shRNA and CNTF promotes retinal ganglion cell survival and axon regeneration. Neuroscience 343:472–482. https://doi.org/10.1016/j.neuroscience.2016.12.027
Chakravarthy H, Beli E, Navitskaya S et al (2016) Imbalances in mobilization and activation of pro-inflammatory and vascular reparative bone marrow-derived cells in diabetic retinopathy. PLoS One 11:e0146829. https://doi.org/10.1371/journal.pone.0146829
Cheung AKH, Fung MKL, Lo ACY et al (2005) Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54:3119–3125
Chhablani J, Sharma A, Goud A et al (2015) Neurodegeneration in type 2 diabetes: evidence from spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 56:6333–6338. https://doi.org/10.1167/iovs.15-17334
Chierzi S, Cenni MC, Maffei L et al (1998) Protection of retinal ganglion cells and preservation of function after optic nerve lesion in bcl-2 transgenic mice. Vis Res 38:1537–1543. https://doi.org/10.1016/S0042-6989(97)00332-5
Colton CA, Wilcock DM (2010) Assessing activation states in microglia. CNS Neurol Disord Drug Targets 9:174–191
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Maguire MG, Martin DF et al (2016) Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology 123:1751–1761. https://doi.org/10.1016/j.ophtha.2016.03.045
Cotrim C, Toscano L, Messias A, et al (2017) Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration. Clin Ophthalmol Volume 11:931–938. doi: https://doi.org/10.2147/OPTH.S133502
Coughlin BA, Feenstra DJ, Mohr S (2017) Müller cells and diabetic retinopathy. Vis Res 139:93–100. https://doi.org/10.1016/j.visres.2017.03.013
de Boer JF, Cense B, Park BH, et al (2003) Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett 28:2067–2069
Devanathan V, Hagedorn I, Köhler D et al (2015) Platelet G i protein Gα i2 is an essential mediator of thrombo-inflammatory organ damage in mice. Proc Natl Acad Sci 112:6491–6496. https://doi.org/10.1073/pnas.1505887112
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, Lachin JM, Genuth S et al (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342:381–389. https://doi.org/10.1056/NEJM200002103420603
Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP et al (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117:1064–1077.e35. https://doi.org/10.1016/j.ophtha.2010.02.031
Divya MS, Rasheed VA, Schmidt T et al (2017) Intraocular injection of ES cell-derived neural progenitors improve visual function in retinal ganglion cell-depleted mouse models. Front Cell Neurosci 11:295. https://doi.org/10.3389/fncel.2017.00295
Du Y, Cramer M, Lee CA et al (2015) Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability. FASEB J Off Publ Fed Am Soc Exp Biol 29:2194–2204. https://doi.org/10.1096/fj.14-269431
Du Y, Tang J, Li G et al (2010) Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function. Invest Ophthalmol Vis Sci 51:2158–2164. https://doi.org/10.1167/iovs.09-3674
Duan X, Krishnaswamy A, De la Huerta I, Sanes JR (2014) Type II cadherins guide assembly of a direction-selective retinal circuit. Cell 158:793–807. https://doi.org/10.1016/j.cell.2014.06.047
Edelhauser HF, Rowe-Rendleman CL, Robinson MR et al (2010) Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci 51:5403–5420. https://doi.org/10.1167/iovs.10-5392
Falavarjani KG, Nguyen QD (2013) Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye Lond Engl 27:787–794. https://doi.org/10.1038/eye.2013.107
Falsini B, Porciatti V, Scalia G et al (1989) Steady-state pattern electroretinogram in insulin-dependent diabetics with no or minimal retinopathy. Doc Ophthalmol Adv Ophthalmol 73:193–200
Feng L, Chen H, Yi J et al (2016) Long-term protection of retinal ganglion cells and visual function by brain-derived neurotrophic factor in mice with ocular hypertension. Invest Ophthalmol Vis Sci 57:3793–3802. https://doi.org/10.1167/iovs.16-19825
Fong DS, Aiello L, Gardner TW et al (2003) Diabetic retinopathy. Diabetes Care 26(Suppl 1):S99–S102
Frank RN (2014) Systemic therapies for diabetic retinopathy: the accord eye study. Ophthalmology 121:2295–2296. https://doi.org/10.1016/j.ophtha.2014.08.019
Fuerst PG, Koizumi A, Masland RH, Burgess RW (2008) Neurite arborization and mosaic spacing in the mouse retina require DSCAM. Nature 451:470–474. https://doi.org/10.1038/nature06514
Gastinger MJ, Kunselman AR, Conboy EE et al (2008) Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. Invest Ophthalmol Vis Sci 49:2635–2642. https://doi.org/10.1167/iovs.07-0683
Gastinger MJ, Singh RSJ, Barber AJ (2006) Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 47:3143–3150. https://doi.org/10.1167/iovs.05-1376
Gonzalez VH, Campbell J, Holekamp NM et al (2016) Early and long-term responses to anti-vascular endothelial growth factor therapy in diabetic macular edema: analysis of protocol I data. Am J Ophthalmol 172:72–79. https://doi.org/10.1016/j.ajo.2016.09.012
Gorsuch RA, Lahne M, Yarka CE et al (2017) Sox2 regulates Müller glia reprogramming and proliferation in the regenerating zebrafish retina via Lin28 and Ascl1a. Exp Eye Res 161:174–192. https://doi.org/10.1016/j.exer.2017.05.012
Gratieri T, Gelfuso GM, Rocha EM et al (2010) A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV 75:186–193. https://doi.org/10.1016/j.ejpb.2010.02.011
Guo M, Liu H, Li S-S et al (2017) Low serum brain-derived neurotrophic factor but not brain-derived neurotrophic factor gene VAL66MET polymorphism is associated with diabetic retinopathy in Chinese type 2 diabetic patients. Retina Phila Pa 37:350–358. https://doi.org/10.1097/IAE.0000000000001132
Guo X, Liu X (2017) Nogo receptor knockdown and ciliary neurotrophic factor attenuate diabetic retinopathy in streptozotocin-induced diabetic rats. Mol Med Rep 16:2030–2036. https://doi.org/10.3892/mmr.2017.6850
Håkansson J, Ståhlberg A, Wolfhagen Sand F et al (2011) N-CAM exhibits a regulatory function in pathological angiogenesis in oxygen induced retinopathy. PLoS One 6:e26026. https://doi.org/10.1371/journal.pone.0026026
Hammer SS, Busik JV (2017) The role of dyslipidemia in diabetic retinopathy. Vis Res 139:228–236. https://doi.org/10.1016/j.visres.2017.04.010
Hammes HP, Federoff HJ, Brownlee M (1995) Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med Camb Mass 1:527–534
Harrison WW, Bearse MA, Ng JS et al (2011) Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci 52:772–777. https://doi.org/10.1167/iovs.10-5931
Hernández C, Bogdanov P, Corraliza L, et al (2016) Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes. Diabetes 65:172–187. doi: https://doi.org/10.2337/db15-0443
Hernández C, García-Ramírez M, Corraliza L et al (2013) Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes. Diabetes 62:2569–2578. https://doi.org/10.2337/db12-0926
Hinze A, Stolzing A (2011) Differentiation of mouse bone marrow derived stem cells toward microglia-like cells. BMC Cell Biol 12:35. https://doi.org/10.1186/1471-2121-12-35
Hirota K, Kaneko Y, Matsumoto G, Hanyu Y (2001) Cadherin expression during retinal regeneration in the adult newt. Zool Sci 18:145–149. https://doi.org/10.2108/zsj.18.145
Hombrebueno JR, Ali IH, Xu H, Chen M (2015) Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2Akita diabetic mouse. Sci Rep 5. https://doi.org/10.1038/srep18316
Hu P, Thinschmidt JS, Yan Y et al (2013) CNS inflammation and bone marrow neuropathy in type 1 diabetes. Am J Pathol 183:1608–1620. https://doi.org/10.1016/j.ajpath.2013.07.009
Huang X, Zhou G, Wu W et al (2017) Genome editing abrogates angiogenesis in vivo. Nat Commun 8:112. https://doi.org/10.1038/s41467-017-00140-3
Hui A, Sheardown H, Jones L (2012) Acetic and acrylic acid molecular imprinted model silicone hydrogel materials for ciprofloxacin-HCl delivery. Mater Basel Switz 5:85–107. https://doi.org/10.3390/ma5010085
Ivanova T, Jalil A, Antoniou Y et al (2016) Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review. Eye Lond Engl 30:645–655. https://doi.org/10.1038/eye.2016.30
Johnson JE, Barde YA, Schwab M, Thoenen H (1986) Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 6:3031–3038
Jorstad NL, Wilken MS, Grimes WN et al (2017) Stimulation of functional neuronal regeneration from Müller glia in adult mice. Nature 548:103–107. https://doi.org/10.1038/nature23283
Joussen AM, Murata T, Tsujikawa A et al (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158:147–152
Kern TS, Berkowitz BA (2015) Photoreceptors in diabetic retinopathy. J Diabetes Investig 6:371–380. https://doi.org/10.1111/jdi.12312
Kern TS, Engerman RL (1996) A mouse model of diabetic retinopathy. Arch Ophthalmol Chic Ill 1960 114:986–990
Kern TS, Tang J, Berkowitz BA (2010) Validation of structural and functional lesions of diabetic retinopathy in mice. Mol Vis 16:2121–2131
Khalaf N, Helmy H, Labib H et al (2017) Role of angiopoietins and Tie-2 in diabetic retinopathy. Electron Physician 9:5031–5035. https://doi.org/10.19082/5031
Kikuchi M, Tenneti L, Lipton SA (2000) Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J Neurosci 20:5037–5044
Kim Y-H, Kim Y-S, Park C-H et al (2008) Protein kinase C-δ mediates neuronal apoptosis in the retinas of diabetic rats via the Akt signaling pathway. Diabetes 57:2181–2190. https://doi.org/10.2337/db07-1431
Kiss S, Berenberg TL (2014) Ultra widefield fundus imaging for diabetic retinopathy. Curr Diab Rep 14:514. https://doi.org/10.1007/s11892-014-0514-0
Klassen HJ, Ng TF, Kurimoto Y et al (2004) Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci 45:4167–4173. https://doi.org/10.1167/iovs.04-0511
Klein R, Klein BE, Moss SE et al (1984) The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol Chic Ill 1960 102:527–532
Kohner EM (2008) Microvascular disease: what does the UKPDS tell us about diabetic retinopathy? Diabet Med J Br Diabet Assoc 25(Suppl 2):20–24. https://doi.org/10.1111/j.1464-5491.2008.02505.x
Kowluru A (2010) Small G proteins in islet beta-cell function. Endocr Rev 31:52–78. https://doi.org/10.1210/er.2009-0022
Kowluru A (2017) Role of G-proteins in islet function in health and diabetes. Diabetes Obes Metab 19(Suppl 1):63–75. https://doi.org/10.1111/dom.13011
Kowluru A, Kowluru RA, Yamazaki A (1992) Functional alterations of G-proteins in diabetic rat retina: a possible explanation for the early visual abnormalities in diabetes mellitus. Diabetologia 35:624–631
Krishnaswamy A, Yamagata M, Duan X et al (2015) Sidekick 2 directs formation of a retinal circuit that detects differential motion. Nature 524:466–470. https://doi.org/10.1038/nature14682
Kur J, Newman EA, Chan-Ling T (2012) Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog Retin Eye Res 31:377–406. https://doi.org/10.1016/j.preteyeres.2012.04.004
Lai AKW, Lo ACY (2013) Animal models of diabetic retinopathy: summary and comparison. J Diabetes Res 2013:106594. https://doi.org/10.1155/2013/106594
Lee VK, Hosking BM, Holeniewska J et al (2018) BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes. Diabetologia. https://doi.org/10.1007/s00125-018-4696-x
Leow CC, Coffman K, Inigo I et al (2012) MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models. Int J Oncol 40:1321–1330. https://doi.org/10.3892/ijo.2012.1366
Li T, Hu J, Du S, et al (2014) ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91- dependent VEGF release in streptozotocin-induced diabetes. Mol Vis 13
Li X, Ma W, Zhuo Y et al (2010) Using neurogenin to reprogram chick RPE to produce photoreceptor-like neurons. Invest Ophthalmol Vis Sci 51:516–525. https://doi.org/10.1167/iovs.09-3822
Lieth E, Gardner TW, Barber AJ et al (2000) Retinal neurodegeneration: early pathology in diabetes. Clin Exp Ophthalmol 28:3–8
Liu Q, Londraville RL, Azodi E et al (2002) Up-regulation of cadherin-2 and cadherin-4 in regenerating visual structures of adult zebrafish. Exp Neurol 177:396–406
Liu X, Zuo Z, Liu W et al (2014) Upregulation of Nogo receptor expression induces apoptosis of retinal ganglion cells in diabetic rats. Neural Regen Res 9:815–820. https://doi.org/10.4103/1673-5374.131597
Liu Y, Leo LF, McGregor C et al (2012) Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice. Mol Med Camb Mass 18:1387–1401. https://doi.org/10.2119/molmed.2012.00008
Lobanovskaya N, Zharkovsky T, Jaako K et al (2015) PSA modification of NCAM supports the survival of injured retinal ganglion cells in adulthood. Brain Res 1625:9–17. https://doi.org/10.1016/j.brainres.2015.08.008
Loeliger MM, Briscoe T, Rees SM (2008) BDNF increases survival of retinal dopaminergic neurons after prenatal compromise. Invest Ophthalmol Vis Sci 49:1282–1289. https://doi.org/10.1167/iovs.07-0521
Lövestam-Adrian M, Agardh E (2000) Photocoagulation of diabetic macular oedema—complications and visual outcome. Acta Ophthalmol Scand 78:667–671
Luke MP, LeVatte TL, O’Reilly AM et al (2016a) Effect of NCAM on aged-related deterioration in vision. Neurobiol Aging 41:93–106. https://doi.org/10.1016/j.neurobiolaging.2016.02.003
Luke MP-S, LeVatte TL, Rutishauser U et al (2016b) Polysialylated neural cell adhesion molecule protects against light-induced retinal degeneration. Invest Ophthalmol Vis Sci 57:5066–5075. https://doi.org/10.1167/iovs.16-19499
Luz-Madrigal A, Grajales-Esquivel E, McCorkle A et al (2014) Reprogramming of the chick retinal pigmented epithelium after retinal injury. BMC Biol 12:28. https://doi.org/10.1186/1741-7007-12-28
Ly A, Yee P, Vessey KA et al (2011) Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss. Invest Ophthalmol Vis Sci 52:9316–9326. https://doi.org/10.1167/iovs.11-7879
Lynch SK, Abràmoff MD (2017) Diabetic retinopathy is a neurodegenerative disorder. Vis Res 139:101–107. https://doi.org/10.1016/j.visres.2017.03.003
Ma W, Yan R-T, Li X, Wang S-Z (2009) Reprogramming retinal pigment epithelium to differentiate toward retinal neurons with Sox2. Stem Cells Dayt Ohio 27:1376–1387. https://doi.org/10.1002/stem.48
MacLaren RE, Pearson RA (2007) Stem cell therapy and the retina. Eye Lond Engl 21:1352–1359. https://doi.org/10.1038/sj.eye.6702842
Marth C, Vergote I, Scambia G et al (2017) ENGOT-ov-6/TRINOVA-2: randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer. Eur J Cancer Oxf Engl 1990 70:111–121. https://doi.org/10.1016/j.ejca.2016.09.004
Martin PM, Roon P, Van Ells TK et al (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330–3336. https://doi.org/10.1167/iovs.04-0247
Masser DR, VanGuilder Starkey HD, Bixler GV et al (2014) Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats. Exp Eye Res 125:95–106. https://doi.org/10.1016/j.exer.2014.06.005
Mathews MK, Guo Y, Langenberg P, Bernstein SL (2015) Ciliary neurotrophic factor (CNTF)-mediated ganglion cell survival in a rodent model of non-arteritic anterior ischaemic optic neuropathy (NAION). Br J Ophthalmol 99:133–137. https://doi.org/10.1136/bjophthalmol-2014-305969
McLeod DS, Lefer DJ, Merges C, Lutty GA (1995) Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147:642–653
McVicar CM, Hamilton R, Colhoun LM et al (2011) Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 60:2995–3005. https://doi.org/10.2337/db11-0026
Meyer-Rüsenberg B, Pavlidis M, Stupp T, Thanos S (2007) Pathological changes in human retinal ganglion cells associated with diabetic and hypertensive retinopathy. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 245:1009–1018. https://doi.org/10.1007/s00417-006-0489-x
Miyamoto K, Khosrof S, Bursell SE et al (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A 96:10836–10841
Mohr S, Xi X, Tang J, Kern TS (2002) Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 51:1172–1179
Murphy JA, Franklin TB, Rafuse VF, Clarke DB (2007a) The neural cell adhesion molecule is necessary for normal adult retinal ganglion cell number and survival. Mol Cell Neurosci 36:280–292. https://doi.org/10.1016/j.mcn.2007.07.006
Murphy JA, Hartwick ATE, Rutishauser U, Clarke DB (2009) Endogenous polysialylated neural cell adhesion molecule enhances the survival of retinal ganglion cells. Invest Ophthalmol Vis Sci 50:861–869. https://doi.org/10.1167/iovs.08-2334
Murphy JA, Nickerson PEB, Clarke DB (2007b) Injury to retinal ganglion cell axons increases polysialylated neural cell adhesion molecule (PSA-NCAM) in the adult rodent superior colliculus. Brain Res 1163:21–32. https://doi.org/10.1016/j.brainres.2007.05.069
Mysona BA, Shanab AY, Elshaer SL, El-Remessy AB (2014) Nerve growth factor in diabetic retinopathy: beyond neurons. Expert Rev Ophthalmol 9:99–107. https://doi.org/10.1586/17469899.2014.903157
Ng JS, Bearse MA, Schneck ME et al (2008) Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci 49:1622–1628. https://doi.org/10.1167/iovs.07-1157
Nguyen QD, Brown DM, Marcus DM et al (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119:789–801. https://doi.org/10.1016/j.ophtha.2011.12.039
Ola MS, Nawaz MI, El-Asrar AA et al (2013) Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats. Cell Mol Neurobiol 33:359–367. https://doi.org/10.1007/s10571-012-9901-8
Oliner JD, Bready J, Nguyen L et al (2012) AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases. Invest Ophthalmol Vis Sci 53:2170–2180. https://doi.org/10.1167/iovs.11-7381
Olivares AM, Althoff K, Chen GF et al (2017) Animal models of diabetic retinopathy. Curr Diab Rep 17:93. https://doi.org/10.1007/s11892-017-0913-0
Osaadon P, Fagan XJ, Lifshitz T, Levy J (2014) A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye Lond Engl 28:510–520. https://doi.org/10.1038/eye.2014.13
Oshitari T, Yoshida-Hata N, Yamamoto S (2010) Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose. Brain Res 1346:43–51. https://doi.org/10.1016/j.brainres.2010.05.073
Park H-YL, Kim JH, Park CK (2014) Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model. Am J Pathol 184:1752–1762. https://doi.org/10.1016/j.ajpath.2014.02.016
Park SS, Bauer G, Abedi M et al (2015) Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest Ophthalmol Vis Sci 56:81–89. https://doi.org/10.1167/iovs.14-15415
Patel JI, Hykin PG, Gregor ZJ et al (2005) Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol 89:480–483. https://doi.org/10.1136/bjo.2004.049940
Pearson CS, Mencio CP, Barber AC, et al (2018) Identification of a critical sulfation in chondroitin that inhibits axonal regeneration. eLife 7:. doi: https://doi.org/10.7554/eLife.37139
Pearson RA, Barber AC, Rizzi M et al (2012) Restoration of vision after transplantation of photoreceptors. Nature 485:99–103. https://doi.org/10.1038/nature10997
Pearson RA, Hippert C, Graca AB, Barber AC (2014) Photoreceptor replacement therapy: challenges presented by the diseased recipient retinal environment. Vis Neurosci 31:333–344. https://doi.org/10.1017/S0952523814000200
Phipps JA, Fletcher EL, Vingrys AJ (2004) Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest Ophthalmol Vis Sci 45:4592–4600. https://doi.org/10.1167/iovs.04-0842
Pollak J, Wilken MS, Ueki Y et al (2013) ASCL1 reprograms mouse Muller glia into neurogenic retinal progenitors. Dev Camb Engl 140:2619–2631. https://doi.org/10.1242/dev.091355
Poulaki V, Qin W, Joussen AM et al (2002) Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest 109:805–815. https://doi.org/10.1172/JCI13776
Qin Y, Xu G, Wang W (2006) Dendritic abnormalities in retinal ganglion cells of three-month diabetic rats. Curr Eye Res 31:967–974. https://doi.org/10.1080/02713680600987674
Rangasamy S, Srinivasan R, Maestas J et al (2011) A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Invest Ophthalmol Vis Sci 52:3784–3791. https://doi.org/10.1167/iovs.10-6386
Regula JT, Lundh von Leithner P, Foxton R et al (2016) Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. EMBO Mol Med 8:1265–1288. https://doi.org/10.15252/emmm.201505889
Reinhard J, Roll L, Faissner A (2017) Tenascins in retinal and optic nerve neurodegeneration. Front Integr Neurosci 11. https://doi.org/10.3389/fnint.2017.00030
Reiter CEN, Wu X, Sandirasegarane L et al (2006) Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin. Diabetes 55:1148–1156
Robinson R, Barathi VA, Chaurasia SS et al (2012) Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech 5:444–456. https://doi.org/10.1242/dmm.009597
Romano MR, Biagioni F, Besozzi G et al (2012) Effects of bevacizumab on neuronal viability of retinal ganglion cells in rats. Brain Res 1478:55–63. https://doi.org/10.1016/j.brainres.2012.08.014
Roy S, Amin S, Roy S (2016) Retinal fibrosis in diabetic retinopathy. Exp Eye Res 142:71–75. https://doi.org/10.1016/j.exer.2015.04.004
Roy S, Kern TS, Song B, Stuebe C (2017) Mechanistic insights into pathological changes in the diabetic retina: Implications for Targeting Diabetic Retinopathy. Am J Pathol 187:9–19. https://doi.org/10.1016/j.ajpath.2016.08.022
Rungger-Brändle E, Dosso AA, Leuenberger PM (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1971–1980
Satarian L, Nourinia R, Safi S et al (2017) Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study. J Ophthalmic Vis Res 12:58–64. https://doi.org/10.4103/2008-322X.200164
Schmidt-Erfurth U, Lang GE, Holz FG et al (2014) Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology 121:1045–1053. https://doi.org/10.1016/j.ophtha.2013.11.041
Schultz DR, Harrington WJ (2003) Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 32:345–369. https://doi.org/10.1053/sarh.2003.50005
Schwartz SD, Regillo CD, Lam BL et al (2015) Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet Lond Engl 385:509–516. https://doi.org/10.1016/S0140-6736(14)61376-3
Seiler MJ, Lin RE, McLelland BT et al (2017) Vision recovery and connectivity by fetal retinal sheet transplantation in an immunodeficient retinal degenerate rat model. Invest Ophthalmol Vis Sci 58:614–630. https://doi.org/10.1167/iovs.15-19028
Sekiguchi H, Ii M, Losordo DW (2009) The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J Cell Physiol 219:235–242. https://doi.org/10.1002/jcp.21672
Sen S, Merchan J, Dean J et al (2010) Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction. Hum Gene Ther 21:1327–1334. https://doi.org/10.1089/hum.2010.006
Simó R (2017) Topical administration of somatostatin and brimonidine in the early stages of diabetic retinopathy
Simó R, Hernández C, European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) (2012) Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol 96:1285–1290. https://doi.org/10.1136/bjophthalmol-2012-302005
Singh MS, Charbel Issa P, Butler R et al (2013) Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation. Proc Natl Acad Sci U S A 110:1101–1106. https://doi.org/10.1073/pnas.1119416110
Singh R, Cuzzani O, Binette F et al (2018) Pluripotent stem cells for retinal tissue engineering: current status and future prospects. Stem Cell Rev 14:463–483. https://doi.org/10.1007/s12015-018-9802-4
Smith SB, Duplantier J, Dun Y et al (2008) In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. Invest Ophthalmol Vis Sci 49:4154–4161. https://doi.org/10.1167/iovs.08-1824
Smith SB, Wang J, Cui X et al (2018) Sigma 1 receptor: a novel therapeutic target in retinal disease. Prog Retin Eye Res. https://doi.org/10.1016/j.preteyeres.2018.07.003
Sohn EH, van Dijk HW, Jiao C et al (2016) Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A 113:E2655–E2664. https://doi.org/10.1073/pnas.1522014113
Stewart MW (2012) Corticosteroid use for diabetic macular edema: old fad or new trend? Curr Diab Rep 12:364–375. https://doi.org/10.1007/s11892-012-0281-8
Thomas CN, Berry M, Logan A et al (2017) Caspases in retinal ganglion cell death and axon regeneration. Cell Death Discov 3:17032. https://doi.org/10.1038/cddiscovery.2017.32
Tochitsky I, Trautman J, Gallerani N et al (2017) Restoring visual function to the blind retina with a potent, safe and long-lasting photoswitch. Sci Rep 7:45487. https://doi.org/10.1038/srep45487
Ueki Y, Wilken MS, Cox KE et al (2015) Transgenic expression of the proneural transcription factor Ascl1 in Müller glia stimulates retinal regeneration in young mice. Proc Natl Acad Sci U S A 112:13717–13722. https://doi.org/10.1073/pnas.1510595112
Unsicker K (2013) Neurotrophic molecules in the treatment of neurodegenerative disease with focus on the retina: status and perspectives. Cell Tissue Res 353:205–218. https://doi.org/10.1007/s00441-013-1585-y
Vadas O, Dbouk HA, Shymanets A et al (2013) Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs). Proc Natl Acad Sci U S A 110:18862–18867. https://doi.org/10.1073/pnas.1304801110
Vagima Y, Lapid K, Kollet O et al (2011) Pathways implicated in stem cell migration: the SDF-1/CXCR4 axis. Methods Mol Biol Clifton NJ 750:277–289. https://doi.org/10.1007/978-1-61779-145-1_19
van Dijk HW, Verbraak FD, Stehouwer M et al (2011) Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy. Vis Res 51:224–228. https://doi.org/10.1016/j.visres.2010.08.024
van Gurp M, Festjens N, van Loo G, et al (2003) Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 304:487–497
Vander JF, Duker JS, Benson WE et al (1991) Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation. Ophthalmology 98:1575–1579
Venugopalan P, Wang Y, Nguyen T et al (2016) Transplanted neurons integrate into adult retinas and respond to light. Nat Commun 7:10472. https://doi.org/10.1038/ncomms10472
Vigneswara V, Ahmed Z (2016) Long-term neuroprotection of retinal ganglion cells by inhibiting caspase-2. Cell Death Discov 2:16044. https://doi.org/10.1038/cddiscovery.2016.44
Vigneswara V, Akpan N, Berry M et al (2014) Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling. Brain J Neurol 137:1656–1675. https://doi.org/10.1093/brain/awu037
Wallick CJ, Hansen RN, Campbell J et al (2015) Comorbidity and health care resource use among commercially insured non-elderly patients with diabetic macular edema. Ophthalmic Surg Lasers Imaging Retina 46:744–751. https://doi.org/10.3928/23258160-20150730-09
Wang J, Saul A, Roon P, Smith SB (2016) Activation of the molecular chaperone, sigma 1 receptor, preserves cone function in a murine model of inherited retinal degeneration. Proc Natl Acad Sci U S A 113:E3764–E3772. https://doi.org/10.1073/pnas.1521749113
Wang Q, Gorbey S, Pfister F et al (2011) Long-term treatment with suberythropoietic Epo is vaso- and neuroprotective in experimental diabetic retinopathy. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 27:769–782. https://doi.org/10.1159/000330085
Wang S-Z, Yan R-T (2014) The retinal pigment epithelium: a convenient source of new photoreceptor cells? J Ophthalmic Vis Res 9:83–93
Wilkinson CP, Ferris FL, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682. https://doi.org/10.1016/S0161-6420(03)00475-5
Williams R, Airey M, Baxter H et al (2004) Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye Lond Engl 18:963–983. https://doi.org/10.1038/sj.eye.6701476
Wolter JR (1961) Diabetic retinopathy. Am J Ophthalmol 51:1123–1141
Wu FTH, Man S, Xu P et al (2016) Efficacy of cotargeting angiopoietin-2 and the VEGF pathway in the adjuvant postsurgical setting for early breast, colorectal, and renal cancers. Cancer Res 76:6988–7000. https://doi.org/10.1158/0008-5472.CAN-16-0888
Xie B, Jiao Q, Cheng Y et al (2012) Effect of pigment epithelium-derived factor on glutamate uptake in retinal Muller cells under high-glucose conditions. Invest Ophthalmol Vis Sci 53:1023–1032. https://doi.org/10.1167/iovs.11-8695
Yang G, Masland RH (1994) Receptive fields and dendritic structure of directionally selective retinal ganglion cells. J Neurosci 14:5267–5280
Yang S, Zhao J, Sun X (2016) Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review. Drug Des Devel Ther 10:1857–1867. https://doi.org/10.2147/DDDT.S97653
Yau JWY, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564. https://doi.org/10.2337/dc11-1909
Yoshida Y, Yamagishi S-I, Matsui T et al (2009) Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy. Diabetes Metab Res Rev 25:678–686. https://doi.org/10.1002/dmrr.1007
Yoshii C, Ueda Y, Okamoto M, Araki M (2007) Neural retinal regeneration in the anuran amphibian Xenopus laevis post-metamorphosis: transdifferentiation of retinal pigmented epithelium regenerates the neural retina. Dev Biol 303:45–56. https://doi.org/10.1016/j.ydbio.2006.11.024
Yue L, Weiland JD, Roska B, Humayun MS (2016) Retinal stimulation strategies to restore vision: fundamentals and systems. Prog Retin Eye Res 53:21–47. https://doi.org/10.1016/j.preteyeres.2016.05.002
Zhang J, Wu Y, Jin Y et al (2008) Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 49:732–742. https://doi.org/10.1167/iovs.07-0721
Zhang SX, Wang JJ, Gao G et al (2006) Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J Off Publ Fed Am Soc Exp Biol 20:323–325. https://doi.org/10.1096/fj.05-4313fje
Zhang W-M, Zhang Z-R, Zhang Y-G, Gao Y-S (2016) Neural stem cell-based intraocular administration of pigment epithelium-derived factor promotes retinal ganglion cell survival and axon regeneration after optic nerve crush injury in rat: an experimental study. Iran J Med Sci 41:382–390
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Chakravarthy, H., Devanathan, V. Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets. J Mol Neurosci 66, 445–461 (2018). https://doi.org/10.1007/s12031-018-1188-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-018-1188-x